slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
232,321-232,380 of 319,975
01
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
03
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
04
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
05
Includes AstraZeneca branding and a molecular visualization background.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
06
Uses a waterfall-bridge style to illustrate revenue growth drivers and headwinds.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
07
The slide uses a structured grid to map high-level strategic goals to specific clinical assets.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
08
The slide uses a three-pillar framework to describe the company's strategic approach to oncology.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
09
The slide uses a grid of cards to present clinical trial names, associated drugs, and key outcomes.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
10
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
11
The slide highlights high-impact clinical trial results presented at two major oncology conferences.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
12
The slide uses a three-row structure to categorize clinical and technological progress.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
13
Includes AstraZeneca branding and slide number 13.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a process diagram to illustrate the mechanism of action and a benefit-chain to explain the clinical advantages of the linker design.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
The slide uses a checkmark/cross comparison matrix to demonstrate the superiority of QCS over IHC.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
The slide uses a process flow diagram to explain the computational pathology workflow.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
Includes a Kaplan-Meier survival curve, a bar chart of prevalence by histology, and a Venn-style diagram illustrating the patient population selection process.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
Includes two Kaplan-Meier plots with embedded summary tables for Non-squamous/non-AGA BEP and Overall BEP populations.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
19
The slide uses a matrix-like layout to map clinical trials to patient segments. The right-hand side provides a strategic summary of the trial program's design principles.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
Illustrates the transition from external lab processing to in-house diagnostic capabilities.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
21
The slide features a 3D rendering of an antibody molecule.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
Includes references to clinical trials (CheckMate 274, AMBASSADOR, NIAGARA) and drug (Imfinzi).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
23
Clinical trial design flow chart.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
24
The slide outlines a hierarchical testing strategy with alpha-exhaustive recycling and gatekeeping.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
25
The slide presents clinical trial baseline data for two study arms.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
26
Includes a table of clinical trial statistics (events, median EFS, HR, P-value) and a risk table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
27
Forest plot showing hazard ratios for Imfinzi vs comparator across clinical subgroups.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
28
Includes 'No. of patients at risk' table and statistical summary table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
29
The slide includes two tables: a primary reconciliation of income statement items and a secondary table detailing the specific adjustments by expense category.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
30
Includes a primary reconciliation table and a detailed breakdown of adjustments by expense category.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
31
The table shows adjustments for special items, impairment, carve-out methodology, deferred markets, foreign tax credits, and other items.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
32
Non-GAAP financial measure reconciliation.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
33
The table provides a bridge between GAAP and non-GAAP financial metrics.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
34
Non-GAAP financial measure reconciliation.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
35
Kenvue | Results Presentation Deck | 37 slidesKenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
36
Data is in millions of dollars and is unaudited.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
37
Kenvue | Results Presentation Deck | 37 slidesKenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
01
Playtika | Results Presentation Deck | 12 slidesPlaytika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · Setup1 hit
02
Playtika | Results Presentation Deck | 12 slidesPlaytika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations 1 hit
03
Includes sequential and year-over-year comparisons for key metrics.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
04
Includes sequential and year-over-year performance data for key products and user metrics.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
05
The slide highlights year-over-year growth/decline percentages for the most recent quarter.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
06
Includes non-GAAP measure disclosure.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
07
The slide highlights the most recent quarter (FY24 Q2) in red and shows the percentage change from the previous period.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
08
The slide displays two stacked bar charts showing percentage contributions for game categories and platform types.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
09
USD in millions.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
10
Standard financial disclosure slide for non-GAAP metrics.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · Evidence1 hit
11
The table provides a detailed breakdown of adjustments including stock-based compensation, impairment of intangible assets, and acquisition-related expenses.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · Evidence1 hit
12
Playtika | Results Presentation Deck | 12 slidesPlaytika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · Reflection1 hit
01
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Attention1 hit
02
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Attention1 hit
03
Includes footnotes explaining revenue basis, session definitions, and non-GAAP EBITDA reconciliation.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · AttentionLoop · Quick Win Big Bet1 hit
04
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
05
The revenue chart is a stacked bar chart showing three segments (Payor, DTE, Consumer). The gross profit chart is a bar chart with overlaid percentage margin labels.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses a stacked bar chart for operating expenses and a waterfall-style bar chart for adjusted EBITDA.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The slide uses a grid-based layout to present strategic pillars leading to a final goal.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
10
Standard financial disclosure slide found in earnings presentations.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Action1 hit
11
Includes footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Action1 hit